Global NASH Council, American Association for the Study of Liver Diseases (AASLD), EASL | The Home of Hepatology, Canadian Association for the Study of the Liver, European Liver Patients' Association - ELPA, Global Liver Institute, Priti Chawla, Obesity Matters, American Diabetes Association Fatty Liver Alliances Post GLP-1 receptor agonists (GLP-1RAs) show promise in managing metabolic dysfunction-associated steatotic liver disease (MASLD) by reducing hepatic steatosis, resolving MASH, and mitigating fibrosis progression
Healthcare providers should educate patients about proper storage during initial prescribing and at follow-up visits
Given the high cost of current GLP-1 receptor agonists, some individuals might find it unaffordable to sustain long-term obesity treatment
In that study, 93% of adverse events associated with oral semaglutide use were the development of nonproliferative DR, and 76% required no intervention
Brand-name GLP-1s can cost $1,000+/month without insurance